3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Breast Neoplasms
26
Prostatic Neoplasms
24
Brain Neoplasms
21
Neoplasms
13
Glioma
10
Head and Neck Neoplasms
8
Pancreatic Neoplasms
7
Glioblastoma
6
Lung Neoplasms
5
Colonic Neoplasms
5
Carcinoma, Hepatocellular
5
Astrocytoma
5
Uterine Cervical Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Rectal Neoplasms
4
Lymphoma
4
Central Nervous System Neoplasms
4
Urinary Bladder Neoplasms
3
Triple Negative Breast Neoplasms
3
Spinal Cord Neoplasms
3
Sarcoma
3
Liver Neoplasms
3
Disease
3
Retinoblastoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pathologic Complete Response
2
Oligodendroglioma
2
Neurofibromatosis 1
2
Meningioma
2
Lymphoma, Non-Hodgkin
2
Interventions
ofatumumab
1
daratumumab
1
Transcranial Direct Current Stimulation
1
Salpingo-oophorectomy
1
Rituximab
1
Magnetic Resonance Imaging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Anti-N-Methyl-D-Aspartate Receptor Encephalitis
×
Magnetic Resonance Imaging
×
Clear all
NCT06915103
2025-04-08
A Case Report of NMDAR Encephalopathy
Mayo Clinic
Completed
1 enrolled